David Michael Clark - Jan 14, 2022 Form 4 Insider Report for AMICUS THERAPEUTICS, INC. (FOLD)

Signature
/s/ Christian Formica, Attorney-in-Fact
Stock symbol
FOLD
Transactions as of
Jan 14, 2022
Transactions value $
-$133,563
Form type
4
Date filed
1/19/2022, 05:46 PM
Previous filing
Jan 4, 2022
Next filing
Aug 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FOLD Common Stock Award +59.1K +39.85% 207K Jan 14, 2022 Direct F1, F2
transaction FOLD Common Stock Award +32.2K +15.55% 240K Jan 14, 2022 Direct F3
transaction FOLD Common Stock Tax liability -$134K -12.7K -5.29% $10.53 227K Jan 14, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FOLD Stock Options (right to buy) Award $0 +108K $0.00 108K Jan 14, 2022 Common Stock 108K $12.11 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Granted in the form of Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Amicus common stock.
F2 The Restricted Stock Units will vest in four equal annual installments beginning on January 3, 2023.
F3 Granted for the achievement of the 2019 PRSU TSR goal as determined by the Board of Directors.
F4 These options vest and become exercisable in a series of installments over a four year period with 25% vesting on January 3, 2023 and the remaining 75% vesting ratably each month thereafter.